Inflammatory disorders

Nearly 5 million asthmatics could benefit from antifungal therapy

An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.

Alzheimer's disease & dementia

Dementia is not the end of learning, finds researcher

People with dementia still have the ability to learn new things despite their illness. This is the conclusion of a doctoral thesis recently presented at Linköping University, Sweden. Its findings debunk the general belief ...

Arthritis & Rheumatism

Copaiba: Silver bullet or snake oil?

Sales of the essential oil copaiba [koh-pey-buh] are increasing, at least in part, because more than 54 million Americans suffer from some form of arthritis and 23.7 million are limited in their usual activity primarily due ...

Alzheimer's disease & dementia

Pinpointing the connection between diet and dementia

Alzheimer's disease is a degenerative disorder affecting between 50 percent and 70 percent of all dementia sufferers. As neurons are killed slowly yet progressively, sufferers experience memory loss and confusion, which worsens ...

Diseases, Conditions, Syndromes

FDA approves first skin patch to combat migraines

(HealthDay News) —A skin patch for the treatment of migraines, and the intense waves of nausea that often accompany these debilitating headaches, has been approved by the U.S. Food and Drug Administration.

page 12 from 24